Alembic Pharma Receives Four Observations From U.S. FDA For Panelav Facility
Earlier on Monday, U.S. health regulator has conducted an inspection at it Panelav facility in Gujarat and issued Form 483 with four procedural observations according to Alembic Pharmaceuticals. “The U.S.…
Pharma sector business in US is going to be the most profitable
– Analysts expect sales to grow by around 15 percent in the first quarter of the fiscal year 2019-2020 led by sales in the US market. – US sales are likely…
